Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roche Diagnostics and Agilent Technologies have signed a non-exclusive licensing agreement for use of Roche's melting curve analysis technology.
Subscribe to our email newsletter
Under the terms of the agreement, Agilent will obtain from Roche a non-exclusive license to use, develop and sell products based on melting curve analysis.
The melting curve analysis is a technique for analysis of polymerase chain reaction (PCR) products. After PCR, the resulting PCR product is slowly heated. Each double-stranded DNA has its own specific melting temperature, which is defined as the temperature at which 50% of the DNA becomes single stranded. By measurement of the melting temperature, the DNA can be easily identified.
Manfred Baier, head of Roche Applied Science, a business area of Roche, said: “The licensing of the melting curve analysis technique to Agilent is one more contribution of Roche to further boost development of this technology in the life science field.”